GoldBamboo.com - Knowledge is strong medicine
  

Environmental Approaches for Obesity Management At Dow - Article


  Not Signed In - Sign In / Register






Obesity

Overweight


Clinical Trial: Environmental Approaches for Obesity Management At Dow

This study is currently recruiting patients.

Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)

Purpose

Design and demonstrate the feasibility of implementing moderate and intensive environmental interventions directed at overweight and obesity prevention at major worksites.
Condition Intervention
Obesity
Cardiovascular Diseases
Heart Diseases
 Behavior: diet
 Behavior: exercise
 Behavior: environment

MedlinePlus related topics:  Heart Diseases;   Obesity;   Vascular Diseases

Study Type: Interventional
Study Design: Prevention

Further Study Details: 

Study start: September 2004;  Expected completion: June 2008

BACKGROUND: More than half of all Americans are overweight or obese, and the prevalence of these risk factors has increased dramatically in the past decade. Obesity is a risk factor for several chronic disease conditions including type-2 diabetes and cardiovascular disease. The national medical cost burden attributable to overweight and obesity is estimated to be between $60 and $93 billion. Business leaders are becoming increasingly aware of the human and economic burden that poor health imposes on their workers. Many employers have invested in health promotion and disease prevention programs aimed at reducing the prevalence of obesity in the workplace through encouragement of physical activity, healthy diet, and improved management of health risk factors. Employers continue to seek innovative and evidence-based interventions that can be imported into the workplace to address a growing public health epidemic that also adversely affects worker productivity.

DESIGN NARRATIVE: The primary objective of the study is to evaluate the marginal effects of introducing two levels of environmental interventions directed at reducing overweight and obesity in the workplace, on top of existing individualized interventions, on five sets of outcomes: a. body mass index and other weight-related biometric measures; b) behavioral health risk factors; c) weight-related health conditions; d) health care utilization and medical expenditures; and e. employee productivity measured in terms of reduced absenteeism and on-the job presenteeism. The design also includes an assessment of costs and benefits of the two treatments, considering the medical, absenteeism and productivity benefits derived from such interventions, an assessment of the impact of the interventions on the worksite climate. Twelve Dow chemical companies will participate in the study. They will be randomly assigned to a moderate environmental treatment, an intensive environmental treatment, or control (individualized treatment only). The moderate interventions will include inexpensive environmental changes (e.g., prompts and reminders), while the high intensity intervention will involve engagement of senior managers in development of a worksite culture that is broadly supportive of improved weight and health management by employees. Annual health screening and biometrics data along with administrative medical claims, absence records, and productivity survey data will be analyzed to determine program impacts. Non-experimental statistical methods will be used to control for baseline differences that remain across sites after randomization. The study will also produce extensive information about how employers can successfully implement environmental treatments at worksites.

Eligibility

Ages Eligible for Study:  18 Years   -   70 Years,  Genders Eligible for Study:  Both
Criteria
No eligibility criteria

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00122928


New York
      Cornell University, Ithaca,  New York,  20003,  United States; Recruiting
Ron Goetzel  202-719-7850    Ron.goetzel@thomson.com 
Ron Goetzel,  Principal Investigator

More Information

Study ID Numbers:  198
Record last reviewed:  July 2005
Last Updated:  July 25, 2005
Record first received:  July 21, 2005
ClinicalTrials.gov Identifier:  NCT00122928
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-07-26


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Obesity.

October 12, 2008



Page Updated: May 11, 2006
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Massachusetts Law | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.